|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |||||||
| 化学式 | C27H26ClN3O7S2 |
||||||||||
| 分子量 | 604.09 | CAS No. | 2260791-14-6 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (165.53 mM) | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | OSMI-4は、細胞におけるEC50が3 μMのO-結合型N-アセチルグルコサミントランスフェラーゼ(O-GlcNAcトランスフェラーゼ、OGT)の阻害剤です。 |
|---|---|
| in vitro | OSMI-4 reduces O-GlcNAc levels almost completely by 5 μM. A decrease in HCF-1 cleavage products and the appearance of uncleaved HCF-1 is observed in cells treated with this compound. This chemical is a kind of structure-based evolution of small molecule OGT inhibitors with low nanomolar binding affinities. It exhibits a ~3 μM EC50 in cells, making it especially attractive for probing OGT’s complex biology. |
| 細胞アッセイ | 細胞株 | HEK293T cells |
|---|---|---|
| 濃度 | 5 μM, 10 μM, 20 μM | |
| 反応時間 | 2 h, 8 h, 16 h, 24 h | |
| 実験の流れ | For quantitative analysis of the proteome, HEK293T cells in fresh media (changed 3 hours before treatment) are treated with 5 and 20 μM OSMI-4 in triplicates, and 10 μM in duplicates (11-plex) or DMSO for 8 hours, 16 hours or 24 hours. At the indicated time point, cells are lysed in lysis buffer (2 % SDS 50 mM Tris-HCl and 150 mM NaCl), sonicated and protein concentration determined with the BCA assay. |
|
| PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth [ Mol Cell, 2025, 85(7):1411-1425.e8] | PubMed: 40132583 |
| O-GlcNAc modulation of nuclear pore complexes orchestrates mRNA export efficiency [ Proc Natl Acad Sci U S A, 2025, 122(32):e2502687122] | PubMed: 40773237 |
| O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma [ Neoplasia, 2025, 62:101142] | PubMed: 40081214 |
| Inhibition of DNMT1 methyltransferase activity via glucose-regulated O-GlcNAcylation alters the epigenome [ Elife, 2023, 12e85595] | PubMed: 37470704 |
| FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer [ Sci Adv, 2023, 9(33):eadg7112] | PubMed: 37595040 |
| O-GlcNAc transferase is important for homology-directed repair [ DNA Repair (Amst), 2022, 119:103394] | PubMed: 36095925 |
| A 2D and 3D cell culture protocol to study O-GlcNAc in sphingosine-1-phosphate mediated fibroblast contraction [ STAR Protoc, 2022, 3(1):101113] | PubMed: 35118425 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。